Wells Fargo’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-332
| Closed | -$58 | – | 7428 |
|
|
2023
Q1 | $58 | Buy |
332
+169
| +104% | +$30 | ﹤0.01% | 6755 |
|
|
2022
Q4 | $65 | Sell |
163
-285
| -64% | -$114 | ﹤0.01% | 6596 |
|
|
2022
Q3 | $0 | Sell |
448
-9
| -2% | – | ﹤0.01% | 7439 |
|
|
2022
Q2 | $1K | Sell |
457
-5,398
| -92% | -$11.8K | ﹤0.01% | 6393 |
|
|
2022
Q1 | $37K | Sell |
5,855
-5,383
| -48% | -$34K | ﹤0.01% | 5460 |
|
|
2021
Q4 | $125K | Sell |
11,238
-1,400
| -11% | -$15.6K | ﹤0.01% | 5129 |
|
|
2021
Q3 | $207K | Buy |
12,638
+12,288
| +3,511% | +$201K | ﹤0.01% | 4797 |
|
|
2021
Q2 | $6K | Sell |
350
-1,677
| -83% | -$28.7K | ﹤0.01% | 5971 |
|
|
2021
Q1 | $31K | Sell |
2,027
-863
| -30% | -$13.2K | ﹤0.01% | 5669 |
|
|
2020
Q4 | $93K | Buy |
+2,890
| New | +$93K | ﹤0.01% | 5219 |
|